Skip to main content
    C

    Crescent Capital BDC Inc (CCAP)

    Official site

    FINANCIAL SERVICES • ASSET MANAGEMENT • NASDAQ

    $10.08
    -0.05 (-0.49%)

    Market Cap: $373.25M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Crescent Capital BDC Inc (CCAP) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Crescent Capital BDC (CCAP) to earn $1.46 per share in the fiscal year ending Dec 31, 2026, on revenue of $147.29M. Of 7 analysts, 2 rate the stock Buy or Strong Buy, 5 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 2.57, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 29% of the ratings.

    RatingAnalystsShare
    Strong Buy114.3%
    Buy114.3%
    Hold571.4%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    7

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus falls 1.4% and revenue estimates fall 4.0%.

    Fiscal year ending Dec 31, 2026
    $1.46
    EPS consensus, revenue $147.29M
    Fiscal year ending Dec 31, 2027
    $1.44
    EPS consensus, revenue $141.44M
    Next report
    Feb 23, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$1.46$1.27 to $1.525$147.29M$146.11M to $148.90M5
    Dec 31, 2027$1.44$1.33 to $1.566$141.44M$130.41M to $153.21M5

    Quarterly Estimates

    The EPS consensus falls from $0.37 for the quarter ending Dec 31, 2026 to $0.35 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.37$0.33 to $0.4110$36.94M$34.39M to $39.69M8
    Mar 31, 2027$0.35$0.33 to $0.386$35.27M$32.92M to $38.40M5

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 5 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202715

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 2.0% from $1.49.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$1.46$1.48$1.48$1.48$1.49-2.2%
    Fiscal year ending Dec 31, 2027$1.44$1.41$1.40$1.40$1.44-0.3%
    Quarter ending Mar 31, 2027$0.35$0.35$0.35$0.35$0.36-1.4%

    Frequently Asked Questions About CCAP

    What is the CCAP stock forecast?

    Consensus analyst estimates put Crescent Capital BDC's EPS at $1.46 for the fiscal year ending Dec 31, 2026, on revenue of $147.29M. The consensus rating from 7 analysts is Hold.

    How do analysts rate CCAP stock?

    Of 7 analysts covering Crescent Capital BDC, 1 rates it Strong Buy, 1 Buy, 5 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from CCAP next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.46, with estimates from $1.27 to $1.52 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.44, with estimates from $1.33 to $1.56 from 6 analysts.

    What revenue do analysts expect from Crescent Capital BDC next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $147.29M, with estimates from $146.11M to $148.90M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $141.44M, with estimates from $130.41M to $153.21M.

    How many analysts cover CCAP?

    7 analysts rate Crescent Capital BDC stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.